Abeona Therapeutics’ Post

View organization page for Abeona Therapeutics, graphic

15,942 followers

Recessive Dystrophic Epidermolysis Bullosa is a rare genetic skin disorder. Children are born without collagen VII. That particular protein helps skin stay on the body. Without it, skin is fragile, it blisters and causes extreme pain every day. To learn more about the journey of those living with RDEB, click here bit.ly/46G4uky Abeona’s BLA submission for pz-cel for RDEB, has been accepted by the FDA for formal review with a PDUFA target action date of May 25, 2024. Read the press release here bit.ly/47SH5NZ #RDEB #raredisease #EBLife #Abeonatherapeutics

To view or add a comment, sign in

Explore topics